Likewise, Sanoyama et al. showed that REV-7 plays an important role in small-cell lung cancer cell survival and proliferation, once again emphasizing the potential therapeutic properties of REV-7 inactivation, possibly through blockage of the TLS pathway, in esophageal SCCs [18]. This evidence concerns the gene MAD2L2 and esophageal squamous cell carcinoma.